These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36584369)

  • 1. The Histological Spectrum and Clinical Significance of T Cell-mediated Rejection of Kidney Allografts.
    Filippone EJ; Farber JL
    Transplantation; 2023 May; 107(5):1042-1055. PubMed ID: 36584369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does tubulitis without interstitial inflammation represent borderline acute T cell mediated rejection?
    Nankivell BJ; P'Ng CH; Chapman JR
    Am J Transplant; 2019 Jan; 19(1):132-144. PubMed ID: 29687946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.
    Lefaucheur C; Gosset C; Rabant M; Viglietti D; Verine J; Aubert O; Louis K; Glotz D; Legendre C; Duong Van Huyen JP; Loupy A
    Am J Transplant; 2018 Feb; 18(2):377-390. PubMed ID: 29086461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection.
    Bouatou Y; Viglietti D; Pievani D; Louis K; Duong Van Huyen JP; Rabant M; Aubert O; Taupin JL; Glotz D; Legendre C; Loupy A; Lefaucheur C
    Am J Transplant; 2019 Jul; 19(7):1972-1988. PubMed ID: 30748089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and pathological significance of borderline T cell-mediated rejection.
    Nankivell BJ; Agrawal N; Sharma A; Taverniti A; P'Ng CH; Shingde M; Wong G; Chapman JR
    Am J Transplant; 2019 May; 19(5):1452-1463. PubMed ID: 30501008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of revised criteria for chronic active T cell-mediated rejection in the 2017 Banff classification: Surveillance by 1-year protocol biopsies for kidney transplantation.
    Nakagawa K; Tsuchimoto A; Ueki K; Matsukuma Y; Okabe Y; Masutani K; Unagami K; Kakuta Y; Okumi M; Nakamura M; Nakano T; Tanabe K; Kitazono T;
    Am J Transplant; 2021 Jan; 21(1):174-185. PubMed ID: 32484280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell mediated rejection revisited: Past, current, and future directions.
    Hara S
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():45-51. PubMed ID: 29968416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bowman capsulitis predicts poor kidney allograft outcome in T cell-mediated rejection.
    Gallan AJ; Chon WJ; Josephson MA; Cunningham PN; Henriksen KJ; Chang A
    Hum Pathol; 2018 Jun; 76():47-51. PubMed ID: 29501487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Perivascular Aggregates in Kidney Allografts: Evaluation of 1-Year Protocol Biopsies Using Recent Banff Classification.
    Masutani K; Nakagawa K; Matsukuma Y; Ueki K; Ataka E; Tsuchimoto A; Okabe Y; Nakamura M; Kitazono T; Nakano T
    Transplant Proc; 2024 Apr; 56(3):499-504. PubMed ID: 38320868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular patterns of isolated tubulitis differ from tubulitis with interstitial inflammation in early indication biopsies of kidney allografts.
    Hruba P; Madill-Thomsen K; Mackova M; Klema J; Maluskova J; Voska L; Parikova A; Slatinska J; Halloran PF; Viklicky O
    Sci Rep; 2020 Dec; 10(1):22220. PubMed ID: 33335257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
    Cherukuri A; Mehta R; Sharma A; Sood P; Zeevi A; Tevar AD; Rothstein DM; Hariharan S
    Kidney Int; 2019 Jul; 96(1):202-213. PubMed ID: 31029504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
    Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion.
    Nankivell BJ; Shingde M; Keung KL; Fung CL; Borrows RJ; O'Connell PJ; Chapman JR
    Am J Transplant; 2018 Feb; 18(2):364-376. PubMed ID: 29194971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary metabolomics for noninvasive detection of borderline and acute T cell-mediated rejection in children after kidney transplantation.
    Blydt-Hansen TD; Sharma A; Gibson IW; Mandal R; Wishart DS
    Am J Transplant; 2014 Oct; 14(10):2339-49. PubMed ID: 25138024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.
    Haas M; Loupy A; Lefaucheur C; Roufosse C; Glotz D; Seron D; Nankivell BJ; Halloran PF; Colvin RB; Akalin E; Alachkar N; Bagnasco S; Bouatou Y; Becker JU; Cornell LD; Duong van Huyen JP; Gibson IW; Kraus ES; Mannon RB; Naesens M; Nickeleit V; Nickerson P; Segev DL; Singh HK; Stegall M; Randhawa P; Racusen L; Solez K; Mengel M
    Am J Transplant; 2018 Feb; 18(2):293-307. PubMed ID: 29243394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts.
    Mueller FB; Yang H; Lubetzky M; Verma A; Lee JR; Dadhania DM; Xiang JZ; Salvatore SP; Seshan SV; Sharma VK; Elemento O; Suthanthiran M; Muthukumar T
    JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rejection of the Renal Allograft in the Absence of Demonstrable Antibody and Complement.
    Zhao X; Huang G; Randhawa S; Zeng G; Lunz J; Randhawa P
    Transplantation; 2017 Feb; 101(2):395-401. PubMed ID: 26901079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of biopsy-based transcript diagnostics to detect T cell-mediated allograft rejection.
    Weidmann L; Harmacek D; Lopez KC; Helmchen BM; Gaspert A; Korach R; Bortel N; Schmid N; von Moos S; Rho E; Schachtner T
    Nephrol Dial Transplant; 2024 Jun; ():. PubMed ID: 38925651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The negative impact of T cell-mediated rejection on renal allograft survival in the modern era.
    Rampersad C; Balshaw R; Gibson IW; Ho J; Shaw J; Karpinski M; Goldberg A; Birk P; Rush DN; Nickerson PW; Wiebe C
    Am J Transplant; 2022 Mar; 22(3):761-771. PubMed ID: 34717048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated Rejection.
    Reeve J; Chang J; Salazar ID; Lopez MM; Halloran PF
    Am J Transplant; 2016 Apr; 16(4):1183-92. PubMed ID: 26730747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.